RxSight (RXST) Short-term Investments (2020 - 2026)

RxSight's Short-term Investments history runs 7 years deep, the most recent figure standing at $200.3 million for Q1 2026.

• Quarterly Short-term Investments fell 0.51% year-over-year to $200.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $200.3 million (down 0.51% YoY) and the FY2025 annual result came in at $208.2 million, down 5.6% from the prior year.
• Short-term Investments was $200.3 million for Q1 2026 at RxSight, down from $208.2 million in the prior quarter.
• Across five years, Short-term Investments topped out at $220.5 million in Q4 2024 and bottomed at $92.7 million in Q1 2024.
• A 5-year average of $157.7 million and a median of $142.9 million in 2023 frame the typical range for Short-term Investments.
• Annual changes were most pronounced in 2022 — Short-term Investments soared 423.13% — and 2024, when it sank 35.14%.
• RxSight's Short-term Investments stood at $94.0 million in 2022, then advanced by 25.03% to $117.5 million in 2023, then soared by 87.69% to $220.5 million in 2024, then dropped by 5.6% to $208.2 million in 2025, then fell by 3.78% to $200.3 million in 2026.
• Business Quant data shows RXST's Short-term Investments at $200.3 million in Q1 2026, $208.2 million in Q4 2025, and $197.9 million in Q3 2025.